Versteeg R, Krüse-Wolters K M, Plomp A C, van Leeuwen A, Stam N J, Ploegh H L, Ruiter D J, Schrier P I
Department of Clinical Oncology, University Hospital Leiden, The Netherlands.
J Exp Med. 1989 Sep 1;170(3):621-35. doi: 10.1084/jem.170.3.621.
The c-myc oncogene downregulates class I HLA expression in human melanoma. The major class I HLA antigens are encoded by three loci, A, B, and C, and we investigated whether these loci are suppressed equally by c-myc. In three melanoma cell lines with high c-myc expression, we analyzed mRNA, protein, and cell surface expression of the class I HLA antigens. Whereas the HLA-B locus expression was found to be strongly reduced, the HLA-A locus was expressed normally. Analysis of c-myc-transfected clones of two melanoma cell lines confirmed that c-myc preferentially suppresses the class I HLA-B locus. Immunohistochemical analysis of fresh melanoma lesions also showed that in the tumors the HLA-A loci are expressed normally, while on the majority of tumor cells no HLA-B antigen expression was found. This downregulation may have consequences for the recognition of malignant cells by tumor-infiltrating lymphocytes. Our results predict that HLA-B-restricted cytotoxic T cells will be unable to kill high c-myc-expressing melanoma cells.
c-myc癌基因可下调人类黑色素瘤中I类HLA的表达。主要的I类HLA抗原由A、B和C三个基因座编码,我们研究了这些基因座是否受到c-myc的同等抑制。在三个c-myc高表达的黑色素瘤细胞系中,我们分析了I类HLA抗原的mRNA、蛋白质和细胞表面表达情况。结果发现HLA-B基因座的表达显著降低,而HLA-A基因座表达正常。对两个黑色素瘤细胞系的c-myc转染克隆进行分析证实,c-myc优先抑制I类HLA-B基因座。对新鲜黑色素瘤病变的免疫组织化学分析还显示,在肿瘤中HLA-A基因座表达正常,而在大多数肿瘤细胞上未发现HLA-B抗原表达。这种下调可能会影响肿瘤浸润淋巴细胞对恶性细胞的识别。我们的结果预测,HLA-B限制性细胞毒性T细胞将无法杀死高表达c-myc的黑色素瘤细胞。